In #MEAction‘s latest announcement, we’ve learned that the National Institute of Allergy and Infection Diseases (NIAID) of NIH recently funded Dr. Derya Unutmaz’s latest grant application. Dr. Unutmaz is the renowned immunologist at the Jackson Laboratory for Genomic Medicine.
[Dr. Unutmaz’s] research focuses on defining the optimal immune response and what happens during infection and chronic disease.
A few years ago Suzanne D. Vernon, PhD was introduced to Dr. Unutmaz, and knew his research focus was a very good fit for ME/CFS. Dr. Unutmaz became intrigued with ME and the ongoing research to uncover its mysteries. He decided to apply to the NIH for funding to expand the numbers of patient samples and types of quantitative analyses on the blood.
The National Institute of Allergy and Infection Diseases (NIAID) of NIH recently funded Dr. Unutmaz’s grant application. He will receive five years of funding – totaling $3,281,515 from the National Institute of Allergy and Infectious Diseases — to find better ways to diagnose and treat ME/CFS. Dr. Lucinda Bateman and Suzanne D. Vernon, PhD are Co-Investigators on this project and the Bateman Horne Center will provide the required blood samples and correlating clinical information for the participating samples.
For too long, research in ME/CFS has been lean and under-funded for several reasons, including the shortage of accurately diagnosed patients available for research studies. The Bateman Horne Center – a clinic specializing in ME/CFS/FM and with a large number of patients who have been carefully and accurately diagnosed, and continue to be treated effectively – will partner with Dr. Unutmaz so that a Research Ready Army of well qualified patients can participate in this exciting research.
See also: Bateman Horne Center
[ Header image from http://www.freewebheaders.com ]
[Alien image from bingdotcom]